+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Fecal Transplant Therapy Market by Type (Capsule-Based Fecal Microbiota Therapy, Liquid-Based Fecal Microbiota Therapy), Disease (Autism Spectrum Disorder, Clostridium Difficile Infection, Diabetes Mellitus), Therapy Procedure, End-User - Global Forecast 2025-2030- Product Image
Fecal Transplant Therapy Market by Type (Capsule-Based Fecal Microbiota Therapy, Liquid-Based Fecal Microbiota Therapy), Disease (Autism Spectrum Disorder, Clostridium Difficile Infection, Diabetes Mellitus), Therapy Procedure, End-User - Global Forecast 2025-2030- Product Image
Sale

Fecal Transplant Therapy Market by Type (Capsule-Based Fecal Microbiota Therapy, Liquid-Based Fecal Microbiota Therapy), Disease (Autism Spectrum Disorder, Clostridium Difficile Infection, Diabetes Mellitus), Therapy Procedure, End-User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 197 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6090073
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Fecal transplant therapy is transforming the healthcare landscape by providing evidence-based solutions for restoring gut microbiota balance and addressing complex clinical needs. Senior decision-makers will find this research offers actionable insights into growth trajectories, evolving practices, and the strategic role of this therapy in patient care.

Market Snapshot: Fecal Transplant Therapy Market Overview

The Fecal Transplant Therapy Market grew from USD 1.90 billion in 2024 to USD 2.02 billion in 2025. With a projected CAGR of 6.48%, the market is anticipated to reach USD 2.77 billion by 2030. Market expansion is driven by increasing adoption in both gastrointestinal and non-gastrointestinal indications. A robust pipeline, broadened regulatory support, and new product formats contribute to steady, long-term growth across all major regions.

Scope & Segmentation: Market Coverage and Technology Evolution

This report thoroughly examines how fecal transplant therapy is utilized, categorized, and adopted worldwide. Coverage spans therapy products, applications, procedures, and user categories, as well as extensive regional dynamics and industry-leading companies.

  • Therapy Types: Capsule-based fecal microbiota therapy; liquid-based fecal microbiota therapy
  • Disease Indications: Autism spectrum disorder; Clostridium difficile infection; diabetes mellitus; inflammatory bowel disease; irritable bowel syndrome; multiple sclerosis; obesity
  • Therapy Procedures: Colonoscopy; enema; nasogastric (NG) tube; oral capsules
  • End-User Sectors: Academic & research institutes; ambulatory surgical centers; hospitals & clinics
  • Regions Covered: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, Russia, Italy, and more), Asia-Pacific (including China, India, Japan, Australia, South Korea, and others)
  • Leading Companies: Key industry players analyzed include AOBiome Therapeutics, Assembly Biosciences, BiomX, Evogene, Ferring Pharmaceuticals, Finch Therapeutics, MaaT Pharma, Nestlé Health Science, OpenBiome, Seres Therapeutics, Takeda Pharmaceutical Company, Theriva Biologics, Vedanta Biosciences, Taconic Biosciences

Key Takeaways for Decision-Makers

  • Fecal transplant therapy is advancing through both capsule-based and liquid-based formulations, meeting diverse patient and procedural needs across clinical settings.
  • Regulatory bodies are enacting more standardized guidelines on donor screening and microbiota handling, which foster broader market confidence and systematic adoption.
  • Adoption is accelerating for outpatient and ambulatory models, with oral capsule delivery simplifying logistics and improving patient experience.
  • New indications, such as metabolic and neuropsychiatric disorders, are expanding the therapy's relevance and attracting investment for broader research and real-world evidence generation.
  • Deployment across regions highlights varying regulatory maturity, infrastructure readiness, and collaborative networks, guiding tailored market-entry strategies and investment priorities.
  • Industry leaders are forming partnerships and investing in process technology, unlocking efficiencies and enabling scalable, standardized therapeutic offerings.

Tariff Impact: Navigating United States Policy Changes

Tariff adjustments in the United States affecting laboratory equipment, reagents, and supply chain components are influencing cost structures for therapy developers and clinical operators. These policy shifts are prompting stakeholders to explore domestic sourcing and localize manufacturing, manage price variability in microbiota preparations, and invest in supply chain resilience measures. The evolving tariff environment is expected to shape industry responses in procurement, production, and distribution strategies for the foreseeable future.

Methodology & Data Sources

This study leverages a comprehensive research methodology combining primary interviews with healthcare professionals and industry experts alongside systematic secondary research from journals, clinical registries, and regulatory guidelines. Analytical frameworks integrate comparative assessments and regional mapping, while expert validations ensure robust, reliable outcomes throughout all research phases.

Why This Report Matters

  • Enables senior leaders to pinpoint strategic growth opportunities and respond proactively to regulatory and tariff changes affecting fecal transplant therapy markets.
  • Provides actionable segmentation and competitor intelligence to inform R&D priorities, clinical service design, and partnership models across global regions.
  • Supports investment and operational planning by clarifying evolving clinical trends, technological innovations, and region-specific adoption dynamics.

Conclusion

Fecal transplant therapy is positioned for continued maturation as scientific research, regulatory frameworks, and operational models evolve. Stakeholders leveraging these insights will be equipped to drive innovation, optimize care delivery, and capitalize on new opportunities within this advancing therapeutic domain.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Personalized microbiome profiling drives targeted fecal transplant treatment protocols
5.2. Integration of fecal transplant therapy with biologics improves outcomes in inflammatory bowel disease
5.3. Emerging synthetic microbiota consortia challenge donor stool services with standardized blends
5.4. Insurance reimbursement reforms expand patient access to fecal microbiota transplant procedures
5.5. AI powered donor screening systems enhance safety and scalability of stool banking operations
5.6. Telehealth platforms streamline donor recruitment and monitoring for remote fecal transplant programs
5.7. Regional market growth in Asia Pacific fueled by increasing clinical trials and local manufacturing
5.8. Pediatric fecal microbiota transplantation gains traction with new safety and efficacy data
5.9. Cross sector partnerships between pharma and microbiome startups boost fecal therapy innovations
5.10. Regulatory approvals accelerate commercialization of standardized fecal transplant therapies
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Fecal Transplant Therapy Market, by Type
8.1. Introduction
8.2. Capsule-Based Fecal Microbiota Therapy
8.3. Liquid-Based Fecal Microbiota Therapy
9. Fecal Transplant Therapy Market, by Disease
9.1. Introduction
9.2. Autism Spectrum Disorder
9.3. Clostridium Difficile Infection
9.4. Diabetes Mellitus
9.5. Inflammatory Bowel Disease
9.6. Irritable Bowel Syndrome
9.7. Multiple Sclerosis
9.8. Obesity
10. Fecal Transplant Therapy Market, by Therapy Procedure
10.1. Introduction
10.2. Colonoscopy
10.3. Enema
10.4. Nasogastric (NG) Tube
10.5. Oral Capsules
11. Fecal Transplant Therapy Market, by End-User
11.1. Introduction
11.2. Academic & Research Institutes
11.3. Ambulatory Surgical Centers
11.4. Hospitals & Clinics
12. Americas Fecal Transplant Therapy Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Fecal Transplant Therapy Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Fecal Transplant Therapy Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. AOBiome Therapeutics, Inc.
15.3.2. Assembly Biosciences, Inc.
15.3.3. BiomX Inc.
15.3.4. Evogene Ltd.
15.3.5. Ferring Pharmaceuticals
15.3.6. Finch Therapeutics Group, Inc.
15.3.7. MaaT Pharma
15.3.8. Nestlé Health Science
15.3.9. OpenBiome
15.3.10. Seres Therapeutics, Inc.
15.3.11. Takeda Pharmaceutical Company Limited
15.3.12. Theriva Biologics, Inc.
15.3.13. Vedanta Biosciences, Inc.
15.3.14. Taconic Biosciences, Inc.
16. Research AI17. Research Statistics18. Research Contacts19. Research Articles20. Appendix
List of Figures
FIGURE 1. FECAL TRANSPLANT THERAPY MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL FECAL TRANSPLANT THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL FECAL TRANSPLANT THERAPY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL FECAL TRANSPLANT THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL FECAL TRANSPLANT THERAPY MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL FECAL TRANSPLANT THERAPY MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL FECAL TRANSPLANT THERAPY MARKET SIZE, BY DISEASE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL FECAL TRANSPLANT THERAPY MARKET SIZE, BY DISEASE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL FECAL TRANSPLANT THERAPY MARKET SIZE, BY THERAPY PROCEDURE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL FECAL TRANSPLANT THERAPY MARKET SIZE, BY THERAPY PROCEDURE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL FECAL TRANSPLANT THERAPY MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL FECAL TRANSPLANT THERAPY MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS FECAL TRANSPLANT THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS FECAL TRANSPLANT THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES FECAL TRANSPLANT THERAPY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES FECAL TRANSPLANT THERAPY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA FECAL TRANSPLANT THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA FECAL TRANSPLANT THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC FECAL TRANSPLANT THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC FECAL TRANSPLANT THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. FECAL TRANSPLANT THERAPY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. FECAL TRANSPLANT THERAPY MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. FECAL TRANSPLANT THERAPY MARKET: RESEARCHAI
FIGURE 24. FECAL TRANSPLANT THERAPY MARKET: RESEARCHSTATISTICS
FIGURE 25. FECAL TRANSPLANT THERAPY MARKET: RESEARCHCONTACTS
FIGURE 26. FECAL TRANSPLANT THERAPY MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. FECAL TRANSPLANT THERAPY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL FECAL TRANSPLANT THERAPY MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL FECAL TRANSPLANT THERAPY MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL FECAL TRANSPLANT THERAPY MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL FECAL TRANSPLANT THERAPY MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL FECAL TRANSPLANT THERAPY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL FECAL TRANSPLANT THERAPY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL FECAL TRANSPLANT THERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL FECAL TRANSPLANT THERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL FECAL TRANSPLANT THERAPY MARKET SIZE, BY CAPSULE-BASED FECAL MICROBIOTA THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL FECAL TRANSPLANT THERAPY MARKET SIZE, BY CAPSULE-BASED FECAL MICROBIOTA THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL FECAL TRANSPLANT THERAPY MARKET SIZE, BY LIQUID-BASED FECAL MICROBIOTA THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL FECAL TRANSPLANT THERAPY MARKET SIZE, BY LIQUID-BASED FECAL MICROBIOTA THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL FECAL TRANSPLANT THERAPY MARKET SIZE, BY DISEASE, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL FECAL TRANSPLANT THERAPY MARKET SIZE, BY DISEASE, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL FECAL TRANSPLANT THERAPY MARKET SIZE, BY AUTISM SPECTRUM DISORDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL FECAL TRANSPLANT THERAPY MARKET SIZE, BY AUTISM SPECTRUM DISORDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL FECAL TRANSPLANT THERAPY MARKET SIZE, BY CLOSTRIDIUM DIFFICILE INFECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL FECAL TRANSPLANT THERAPY MARKET SIZE, BY CLOSTRIDIUM DIFFICILE INFECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL FECAL TRANSPLANT THERAPY MARKET SIZE, BY DIABETES MELLITUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL FECAL TRANSPLANT THERAPY MARKET SIZE, BY DIABETES MELLITUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL FECAL TRANSPLANT THERAPY MARKET SIZE, BY INFLAMMATORY BOWEL DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL FECAL TRANSPLANT THERAPY MARKET SIZE, BY INFLAMMATORY BOWEL DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL FECAL TRANSPLANT THERAPY MARKET SIZE, BY IRRITABLE BOWEL SYNDROME, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL FECAL TRANSPLANT THERAPY MARKET SIZE, BY IRRITABLE BOWEL SYNDROME, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL FECAL TRANSPLANT THERAPY MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL FECAL TRANSPLANT THERAPY MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL FECAL TRANSPLANT THERAPY MARKET SIZE, BY OBESITY, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL FECAL TRANSPLANT THERAPY MARKET SIZE, BY OBESITY, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL FECAL TRANSPLANT THERAPY MARKET SIZE, BY THERAPY PROCEDURE, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL FECAL TRANSPLANT THERAPY MARKET SIZE, BY THERAPY PROCEDURE, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL FECAL TRANSPLANT THERAPY MARKET SIZE, BY COLONOSCOPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL FECAL TRANSPLANT THERAPY MARKET SIZE, BY COLONOSCOPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL FECAL TRANSPLANT THERAPY MARKET SIZE, BY ENEMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL FECAL TRANSPLANT THERAPY MARKET SIZE, BY ENEMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL FECAL TRANSPLANT THERAPY MARKET SIZE, BY NASOGASTRIC (NG) TUBE, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL FECAL TRANSPLANT THERAPY MARKET SIZE, BY NASOGASTRIC (NG) TUBE, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL FECAL TRANSPLANT THERAPY MARKET SIZE, BY ORAL CAPSULES, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL FECAL TRANSPLANT THERAPY MARKET SIZE, BY ORAL CAPSULES, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL FECAL TRANSPLANT THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL FECAL TRANSPLANT THERAPY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL FECAL TRANSPLANT THERAPY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL FECAL TRANSPLANT THERAPY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL FECAL TRANSPLANT THERAPY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL FECAL TRANSPLANT THERAPY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL FECAL TRANSPLANT THERAPY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL FECAL TRANSPLANT THERAPY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. AMERICAS FECAL TRANSPLANT THERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 50. AMERICAS FECAL TRANSPLANT THERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 51. AMERICAS FECAL TRANSPLANT THERAPY MARKET SIZE, BY DISEASE, 2018-2024 (USD MILLION)
TABLE 52. AMERICAS FECAL TRANSPLANT THERAPY MARKET SIZE, BY DISEASE, 2025-2030 (USD MILLION)
TABLE 53. AMERICAS FECAL TRANSPLANT THERAPY MARKET SIZE, BY THERAPY PROCEDURE, 2018-2024 (USD MILLION)
TABLE 54. AMERICAS FECAL TRANSPLANT THERAPY MARKET SIZE, BY THERAPY PROCEDURE, 2025-2030 (USD MILLION)
TABLE 55. AMERICAS FECAL TRANSPLANT THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 56. AMERICAS FECAL TRANSPLANT THERAPY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 57. AMERICAS FECAL TRANSPLANT THERAPY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 58. AMERICAS FECAL TRANSPLANT THERAPY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 59. UNITED STATES FECAL TRANSPLANT THERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 60. UNITED STATES FECAL TRANSPLANT THERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 61. UNITED STATES FECAL TRANSPLANT THERAPY MARKET SIZE, BY DISEASE, 2018-2024 (USD MILLION)
TABLE 62. UNITED STATES FECAL TRANSPLANT THERAPY MARKET SIZE, BY DISEASE, 2025-2030 (USD MILLION)
TABLE 63. UNITED STATES FECAL TRANSPLANT THERAPY MARKET SIZE, BY THERAPY PROCEDURE, 2018-2024 (USD MILLION)
TABLE 64. UNITED STATES FECAL TRANSPLANT THERAPY MARKET SIZE, BY THERAPY PROCEDURE, 2025-2030 (USD MILLION)
TABLE 65. UNITED STATES FECAL TRANSPLANT THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 66. UNITED STATES FECAL TRANSPLANT THERAPY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 67. UNITED STATES FECAL TRANSPLANT THERAPY MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 68. UNITED STATES FECAL TRANSPLANT THERAPY MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 69. CANADA FECAL TRANSPLANT THERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 70. CANADA FECAL TRANSPLANT THERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 71. CANADA FECAL TRANSPLANT THERAPY MARKET SIZE, BY DISEASE, 2018-2024 (USD MILLION)
TABLE 72. CANADA FECAL TRANSPLANT THERAPY MARKET SIZE, BY DISEASE, 2025-2030 (USD MILLION)
TABLE 73. CANADA FECAL TRANSPLANT THERAPY MARKET SIZE, BY THERAPY PROCEDURE, 2018-2024 (USD MILLION)
TABLE 74. CANADA FECAL TRANSPLANT THERAPY MARKET SIZE, BY THERAPY PROCEDURE, 2025-2030 (USD MILLION)
TABLE 75. CANADA FECAL TRANSPLANT THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 76. CANADA FECAL TRANSPLANT THERAPY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 77. MEXICO FECAL TRANSPLANT THERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 78. MEXICO FECAL TRANSPLANT THERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 79. MEXICO FECAL TRANSPLANT THERAPY MARKET SIZE, BY DISEASE, 2018-2024 (USD MILLION)
TABLE 80. MEXICO FECAL TRANSPLANT THERAPY MARKET SIZE, BY DISEASE, 2025-2030 (USD MILLION)
TABLE 81. MEXICO FECAL TRANSPLANT THERAPY MARKET SIZE, BY THERAPY PROCEDURE, 2018-2024 (USD MILLION)
TABLE 82. MEXICO FECAL TRANSPLANT THERAPY MARKET SIZE, BY THERAPY PROCEDURE, 2025-2030 (USD MILLION)
TABLE 83. MEXICO FECAL TRANSPLANT THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 84. MEXICO FECAL TRANSPLANT THERAPY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 85. BRAZIL FECAL TRANSPLANT THERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 86. BRAZIL FECAL TRANSPLANT THERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 87. BRAZIL FECAL TRANSPLANT THERAPY MARKET SIZE, BY DISEASE, 2018-2024 (USD MILLION)
TABLE 88. BRAZIL FECAL TRANSPLANT THERAPY MARKET SIZE, BY DISEASE, 2025-2030 (USD MILLION)
TABLE 89. BRAZIL FECAL TRANSPLANT THERAPY MARKET SIZE, BY THERAPY PROCEDURE, 2018-2024 (USD MILLION)
TABLE 90. BRAZIL FECAL TRANSPLANT THERAPY MARKET SIZE, BY THERAPY PROCEDURE, 2025-2030 (USD MILLION)
TABLE 91. BRAZIL FECAL TRANSPLANT THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 92. BRAZIL FECAL TRANSPLANT THERAPY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 93. ARGENTINA FECAL TRANSPLANT THERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 94. ARGENTINA FECAL TRANSPLANT THERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 95. ARGENTINA FECAL TRANSPLANT THERAPY MARKET SIZE, BY DISEASE, 2018-2024 (USD MILLION)
TABLE 96. ARGENTINA FECAL TRANSPLANT THERAPY MARKET SIZE, BY DISEASE, 2025-2030 (USD MILLION)
TABLE 97. ARGENTINA FECAL TRANSPLANT THERAPY MARKET SIZE, BY THERAPY PROCEDURE, 2018-2024 (USD MILLION)
TABLE 98. ARGENTINA FECAL TRANSPLANT THERAPY MARKET SIZE, BY THERAPY PROCEDURE, 2025-2030 (USD MILLION)
TABLE 99. ARGENTINA FECAL TRANSPLANT THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 100. ARGENTINA FECAL TRANSPLANT THERAPY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA FECAL TRANSPLANT THERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA FECAL TRANSPLANT THERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA FECAL TRANSPLANT THERAPY MARKET SIZE, BY DISEASE, 2018-2024 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA FECAL TRANSPLANT THERAPY MARKET SIZE, BY DISEASE, 2025-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA FECAL TRANSPLANT THERAPY MARKET SIZE, BY THERAPY PROCEDURE, 2018-2024 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA FECAL TRANSPLANT THERAPY MARKET SIZE, BY THERAPY PROCEDURE, 2025-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA FECAL TRANSPLANT THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA FECAL TRANSPLANT THERAPY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA FECAL TRANSPLANT THERAPY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA FECAL TRANSPLANT THERAPY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 111. UNITED KINGDOM FECAL TRANSPLANT THERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 112. UNITED KINGDOM FECAL TRANSPLANT THERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 113. UNITED KINGDOM FECAL TRANSPLANT THERAPY MARKET SIZE, BY DISEASE, 2018-2024 (USD MILLION)
TABLE 114. UNITED KINGDOM FECAL TRANSPLANT THERAPY MARKET SIZE, BY DISEASE, 2025-2030 (USD MILLION)
TABLE 115. UNITED KINGDOM FECAL TRANSPLANT THERAPY MARKET SIZE, BY THERAPY PROCEDURE, 2018-2024 (USD MILLION)
TABLE 116. UNITED KINGDOM FECAL TRANSPLANT THERAPY MARKET SIZE, BY THERAPY PROCEDURE, 2025-2030 (USD MILLION)
TABLE 117. UNITED KINGDOM FECAL TRANSPLANT THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 118. UNITED KINGDOM FECAL TRANSPLANT THERAPY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 119. GERMANY FECAL TRANSPLANT THERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 120. GERMANY FECAL TRANSPLANT THERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 121. GERMANY FECAL TRANSPLANT THERAPY MARKET SIZE, BY DISEASE, 2018-2024 (USD MILLION)
TABLE 122. GERMANY FECAL TRANSPLANT THERAPY MARKET SIZE, BY DISEASE, 2025-2030 (USD MILLION)
TABLE 123. GERMANY FECAL TRANSPLANT THERAPY MARKET SIZE, BY THERAPY PROCEDURE, 2018-2024 (USD MILLION)
TABLE 124. GERMANY FECAL TRANSPLANT THERAPY MARKET SIZE, BY THERAPY PROCEDURE, 2025-2030 (USD MILLION)
TABLE 125. GERMANY FECAL TRANSPLANT THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 126. GERMANY FECAL TRANSPLANT THERAPY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 127. FRANCE FECAL TRANSPLANT THERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 128. FRANCE FECAL TRANSPLANT THERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 129. FRANCE FECAL TRANSPLANT THERAPY MARKET SIZE, BY DISEASE, 2018-2024 (USD MILLION)
TABLE 130. FRANCE FECAL TRANSPLANT THERAPY MARKET SIZE, BY DISEASE, 2025-2030 (USD MILLION)
TABLE 131. FRANCE FECAL TRANSPLANT THERAPY MARKET SIZE, BY THERAPY PROCEDURE, 2018-2024 (USD MILLION)
TABLE 132. FRANCE FECAL TRANSPLANT THERAPY MARKET SIZE, BY THERAPY PROCEDURE, 2025-2030 (USD MILLION)
TABLE 133. FRANCE FECAL TRANSPLANT THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 134. FRANCE FECAL TRANSPLANT THERAPY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 135. RUSSIA FECAL TRANSPLANT THERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 136. RUSSIA FECAL TRANSPLANT THERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 137. RUSSIA FECAL TRANSPLANT THERAPY MARKET SIZE, BY DISEASE, 2018-2024 (USD MILLION)
TABLE 138. RUSSIA FECAL TRANSPLANT THERAPY MARKET SIZE, BY DISEASE, 2025-2030 (USD MILLION)
TABLE 139. RUSSIA FECAL TRANSPLANT THERAPY MARKET SIZE, BY THERAPY PROCEDURE, 2018-2024 (USD MILLION)
TABLE 140. RUSSIA FECAL TRANSPLANT THERAPY MARKET SIZE, BY THERAPY PROCEDURE, 2025-2030 (USD MILLION)
TABLE 141. RUSSIA FECAL TRANSPLANT THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 142. RUSSIA FECAL TRANSPLANT THERAPY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 143. ITALY FECAL TRANSPLANT THERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 144. ITALY FECAL TRANSPLANT THERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 145. ITALY FECAL TRANSPLANT THERAPY MARKET SIZE, BY DISEASE, 2018-2024 (USD MILLION)
TABLE 146. ITALY FECAL TRANSPLANT THERAPY MARKET SIZE, BY DISEASE, 2025-2030 (USD MILLION)
TABLE 147. ITALY FECAL TRANSPLANT THERAPY MARKET SIZE, BY THERAPY PROCEDURE, 2018-2024 (USD MILLION)
TABLE 148. ITALY FECAL TRANSPLANT THERAPY MARKET SIZE, BY THERAPY PROCEDURE, 2025-2030 (USD MILLION)
TABLE 149. ITALY FECAL TRANSPLANT THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 150. ITALY FECAL TRANSPLANT THERAPY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 151. SPAIN FECAL TRANSPLANT THERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 152. SPAIN FECAL TRANSPLANT THERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 153. SPAIN FECAL TRANSPLANT THERAPY MARKET SIZE, BY DISEASE, 2018-2024 (USD MILLION)
TABLE 154. SPAIN FECAL TRANSPLANT THERAPY MARKET SIZE, BY DISEASE, 2025-2030 (USD MILLION)
TABLE 155. SPAIN FECAL TRANSPLANT THERAPY MARKET SIZE, BY THERAPY PROCEDURE, 2018-2024 (USD MILLION)
TABLE 156. SPAIN FECAL TRANSPLANT THERAPY MARKET SIZE, BY THERAPY PROCEDURE, 2025-2030 (USD MILLION)
TABLE 157. SPAIN FECAL TRANSPLANT THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 158. SPAIN FECAL TRANSPLANT THERAPY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 159. UNITED ARAB EMIRATES FECAL TRANSPLANT THERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 160. UNITED ARAB EMIRATES FECAL TRANSPLANT THERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 161. UNITED ARAB EMIRATES FECAL TRANSPLANT THERAPY MARKET SIZE, BY DISEASE, 2018-2024 (USD MILLION)
TABLE 162. UNITED ARAB EMIRATES FECAL TRANSPLANT THERAPY MARKET SIZE, BY DISEASE, 2025-2030 (USD MILLION)
TABLE 163. UNITED ARAB EMIRATES FECAL TRANSPLANT THERAPY MARKET SIZE, BY THERAPY PROCEDURE, 2018-2024 (USD MILLION)
TABLE 164. UNITED ARAB EMIRATES FECAL TRANSPLANT THERAPY MARKET SIZE, BY THERAPY PROCEDURE, 2025-2030 (USD MILLION)
TABLE 165. UNITED ARAB EMIRATES FECAL TRANSPLANT THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 166. UNITED ARAB EMIRATES FECAL TRANSPLANT THERAPY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 167. SAUDI ARABIA FECAL TRANSPLANT THERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 168. SAUDI ARABIA FECAL TRANSPLANT THERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 169. SAUDI ARABIA FECAL TRANSPLANT THERAPY MARKET SIZE, BY DISEASE, 2018-2024 (USD MILLION)
TABLE 170. SAUDI ARABIA FECAL TRANSPLANT THERAPY MARKET SIZE, BY DISEASE, 2025-2030 (USD MILLION)
TABLE 171. SAUDI ARABIA FECAL TRANSPLANT THERAPY MARKET SIZE, BY THERAPY PROCEDURE, 2018-2024 (USD MILLION)
TABLE 172. SAUDI ARABIA FECAL TRANSPLANT THERAPY MARKET SIZE, BY THERAPY PROCEDURE, 2025-2030 (USD MILLION)
TABLE 173. SAUDI ARABIA FECAL TRANSPLANT THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 174. SAUDI ARABIA FECAL TRANSPLANT THERAPY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 175. SOUTH AFRICA FECAL TRANSPLANT THERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 176. SOUTH AFRICA FECAL TRANSPLANT THERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 177. SOUTH AFRICA FECAL TRANSPLANT THERAPY MARKET SIZE, BY DISEASE, 2018-2024 (USD MILLION)
TABLE 178. SOUTH AFRICA FECAL TRANSPLANT THERAPY MARKET SIZE, BY DISEASE, 2025-2030 (USD MILLION)
TABLE 179. SOUTH AFRICA FECAL TRANSPLANT THERAPY MARKET SIZE, BY THERAPY PROCEDURE, 2018-2024 (USD MILLION)
TABLE 180. SOUTH AFRICA FECAL TRANSPLANT THERAPY MARKET SIZE, BY THERAPY PROCEDURE, 2025-2030 (USD MILLION)
TABLE 181. SOUTH AFRICA FECAL TRANSPLANT THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 182. SOUTH AFRICA FECAL TRANSPLANT THERAPY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 183. DENMARK FECAL TRANSPLANT THERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 184. DENMARK FECAL TRANSPLANT THERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 185. DENMARK FECAL TRANSPLANT THERAPY MARKET SIZE, BY DISEASE, 2018-2024 (USD MILLION)
TABLE 186. DENMARK FECAL TRANSPLANT THERAPY MARKET SIZE, BY DISEASE, 2025-2030 (USD MILLION)
TABLE 187. DENMARK FECAL TRANSPLANT THERAPY MARKET SIZE, BY THERAPY PROCEDURE, 2018-2024 (USD MILLION)
TABLE 188. DENMARK FECAL TRANSPLANT THERAPY MARKET SIZE, BY THERAPY PROCEDURE, 2025-2030 (USD MILLION)
TABLE 189. DENMARK FECAL TRANSPLANT THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 190. DENMARK FECAL TRANSPLANT THERAPY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 191. NETHERLANDS FECAL TRANSPLANT THERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 192. NETHERLANDS FECAL TRANSPLANT THERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 193. NETHERLANDS FECAL TRANSPLANT THERAPY MARKET SIZE, BY DISEASE, 2018-2024 (USD MILLION)
TABLE 194. NETHERLANDS FECAL TRANSPLANT THERAPY MARKET SIZE, BY DISEASE, 2025-2030 (USD MILLION)
TABLE 195. NETHERLANDS FECAL TRANSPLANT THERAPY MARKET SIZE, BY THERAPY PROCEDURE, 2018-2024 (USD MILLION)
TABLE 196. NETHERLANDS FECAL TRANSPLANT THERAPY MARKET SIZE, BY THERAPY PROCEDURE, 2025-2030 (USD MILLION)
TABLE 197. NETHERLANDS FECAL TRANSPLANT THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 198. NETHERLANDS FECAL TRANSPLANT THERAPY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 199. QATAR FECAL TRANSPLANT THERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 200. QATAR FECAL TRANSPLANT THERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 201. QATAR FECAL TRANSPLANT THERAPY MARKET SIZE, BY DISEASE, 2018-2024 (USD MILLION)
TABLE 202. QATAR FECAL TRANSPLANT THERAPY MARKET SIZE, BY DISEASE, 2025-2030 (USD MILLION)
TABLE 203. QATAR FECAL TRANSPLANT THERAPY MARKET SIZE, BY THERAPY PROCEDURE, 2018-2024 (USD MILLION)
TABLE 204. QATAR FECAL TRANSPLANT THERAPY MARKET SIZE, BY THERAPY PROCEDURE, 2025-2030 (USD MILLION)
TABLE 205. QATAR FECAL TRANSPLANT THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 206. QATAR FECAL TRANSPLANT THERAPY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 207. FINLAND FECAL TRANSPLANT THERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 208. FINLAND FECAL TRANSPLANT THERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 209. FINLAND FECAL TRANSPLANT THERAPY MARKET SIZE, BY DISEASE, 2018-2024 (USD MILLION)
TABLE 210. FINLAND FECAL TRANSPLANT THERAPY MARKET SIZE, BY DISEASE, 2025-2030 (USD MILLION)
TABLE 211. FINLAND FECAL TRANSPLANT THERAPY MARKET SIZE, BY THERAPY PROCEDURE, 2018-2024 (USD MILLION)
TABLE 212. FINLAND FECAL TRANSPLANT THERAPY MARKET SIZE, BY THERAPY PROCEDURE, 2025-2030 (USD MILLION)
TABLE 213. FINLAND FECAL TRANSPLANT THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 214. FINLAND FECAL TRANSPLANT THERAPY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 215. SWEDEN FECAL TRANSPLANT THERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 216. SWEDEN FECAL TRANSPLANT THERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 217. SWEDEN FECAL TRANSPLANT THERAPY MARKET SIZE, BY DISEASE, 2018-2024 (USD MILLION)
TABLE 218. SWEDEN FECAL TRANSPLANT THERAPY MARKET SIZE, BY DISEASE, 2025-2030 (USD MILLION)
TABLE 219. SWEDEN FECAL TRANSPLANT THERAPY MARKET SIZE, BY THERAPY PROCEDURE, 2018-2024 (USD MILLION)
TABLE 220. SWEDEN FECAL TRANSPLANT THERAPY MARKET SIZE, BY THERAPY PROCEDURE, 2025-2030 (USD MILLION)
TABLE 221. SWEDEN FECAL TRANSPLANT THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 222. SWEDEN FECAL TRANSPLANT THERAPY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 223. NIGERIA FECAL TRANSPLANT THERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 224. NIGERIA FECAL TRANSPLANT THERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 225. NIGERIA FECAL TRANSPLANT THERAPY MARKET SIZE, BY DISEASE, 2018-2024 (USD MILLION)
TABLE 226. NIGERIA FECAL TRANSPLANT THERAPY MARKET SIZE, BY DISEASE, 2025-2030 (USD MILLION)
TABLE 227. NIGERIA FECAL TRANSPLANT THERAPY MARKET SIZE, BY THERAPY PROCEDURE, 2018-2024 (USD MILLION)
TABLE 228. NIGERIA FECAL TRANSPLANT THERAPY MARKET SIZE, BY THERAPY PROCEDURE, 2025-2030 (USD MILLION)
TABLE 229. NIGERIA FECAL TRANSPLANT THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 230. NIGERIA FECAL TRANSPLANT THERAPY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 231. EGYPT FECAL TRANSPLANT THERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 232. EGYPT FECAL TRANSPLANT THERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 233. EGYPT FECAL TRANSPLANT THERAPY MARKET SIZE, BY DISEASE, 2018-2024 (USD MILLION)
TABLE 234. EGYPT FECAL TRANSPLANT THERAPY MARKET SIZE, BY DISEASE, 2025-2030 (USD MILLION)
TABLE 235. EGYPT FECAL TRANSPLANT THERAPY MARKET SIZE, BY THERAPY PROCEDURE, 2018-2024 (USD MILLION)
TABLE 236. EGYPT FECAL TRANSPLANT THERAPY MARKET SIZE, BY THERAPY PROCEDURE, 2025-2030 (USD MILLION)
TABLE 237. EGYPT FECAL TRANSPLANT THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 238. EGYPT FECAL TRANSPLANT THERAPY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 239. TURKEY FECAL TRANSPLANT THERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 240. TURKEY FECAL TRANSPLANT THERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 241. TURKEY FECAL TRANSPLANT THERAPY MARKET SIZE, BY DISEASE, 2018-2024 (USD MILLION)
TABLE 242. TURKEY FECAL TRANSPLANT THERAPY MARKET SIZE, BY DISEASE, 2025-2030 (USD MILLION)
TABLE 243. TURKEY FECAL TRANSPLANT THERAPY MARKET SIZE, BY THERAPY PROCEDURE, 2018-2024 (USD MILLION)
TABLE 244. TURKEY FECAL TRANSPLANT THERAPY MARKET SIZE, BY THERAPY PROCEDURE, 2025-2030 (USD MILLION)
TABLE 245. TURKEY FECAL TRANSPLANT THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 246. TURKEY FECAL TRANSPLANT THERAPY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 247. ISRAEL FECAL TRANSPLANT THERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 248. ISRAEL FECAL TRANSPLANT THERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 249. ISRAEL FECAL TRANSPLANT THERAPY MARKET SIZE, BY DISEASE, 2018-2024 (USD MILLION)
TABLE 250. ISRAEL FECAL TRANSPLANT THERAPY MARKET SIZE, BY DISEASE, 2025-2030 (USD MILLION)
TABLE 251. ISRAEL FECAL TRANSPLANT THERAPY MARKET SIZE, BY THERAPY PROCEDURE, 2018-2024 (USD MILLION)
TABLE 252. ISRAEL FECAL TRANSPLANT THERAPY MARKET SIZE, BY THERAPY PROCEDURE, 2025-2030 (USD MILLION)
TABLE 253. ISRAEL FECAL TRANSPLANT THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 254. ISRAEL FECAL TRANSPLANT THERAPY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 255. NORWAY FECAL TRANSPLANT THERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 256. NORWAY FECAL TRANSPLANT THERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 257. NORWAY FECAL TRANSPLANT THERAPY MARKET SIZE, BY DISEASE, 2018-2024 (USD MILLION)
TABLE 258. NORWAY FECAL TRANSPLANT THERAPY MARKET SIZE, BY DISEASE, 2025-2030 (USD MILLION)
TABLE 259. NORWAY FECAL TRANSPLANT THERAPY MARKET SIZE, BY THERAPY PROCEDURE, 2018-2024 (USD MILLION)
TABLE 260. NORWAY FECAL TRANSPLANT THERAPY MARKET SIZE, BY THERAPY PROCEDURE, 2025-2030 (USD MILLION)
TABLE 261. NORWAY FECAL TRANSPLANT THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 262. NORWAY FECAL TRANSPLANT THERAPY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 263. POLAND FECAL TRANSPLANT THERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 264. POLAND FECAL TRANSPLANT THERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 265. POLAND FECAL TRANSPLANT THERAPY MARKET SIZE, BY DISEASE, 2018-2024 (USD MILLION)
TABLE 266. POLAND FECAL TRANSPLANT THERAPY MARKET SIZE, BY DISEASE, 2025-2030 (USD MILLION)
TABLE 267. POLAND FECAL TRANSPLANT THERAPY MARKET SIZE, BY THERAPY PROCEDURE, 2018-2024 (USD MILLION)
TABLE 268. POLAND FECAL TRANSPLANT THERAPY MARKET SIZE, BY THERAPY PROCEDURE, 2025-2030 (USD MILLION)
TABLE 269. POLAND FECAL TRANSPLANT THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 270. POLAND FECAL TRANSPLANT THERAPY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 271. SWITZERLAND FECAL TRANSPLANT THERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 272. SWITZERLAND FECAL TRANSPLANT THERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 273. SWITZERLAND FECAL TRANSPLANT THERAPY MARKET SIZE, BY DISEASE, 2018-2024 (USD MILLION)
TABLE 274. SWITZERLAND FECAL TRANSPLANT THERAPY MARKET SIZE, BY DISEASE, 2025-2030 (USD MILLION)
TABLE 275. SWITZERLAND FECAL TRANSPLANT THERAPY MARKET SIZE, BY THERAPY PROCEDURE, 2018-2024 (USD MILLION)
TABLE 276. SWITZERLAND FECAL TRANSPLANT THERAPY MARKET SIZE, BY THERAPY PROCEDURE, 2025-2030 (USD MILLION)
TABLE 277. SWITZERLAND FECAL TRANSPLANT THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 278. SWITZERLAND FECAL TRANSPLANT THERAPY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 279. ASIA-PACIFIC FECAL TRANSPLANT THERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 280. ASIA-PACIFIC FECAL TRANSPLANT THERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 281. ASIA-PACIFIC FECAL TRANSPLANT THERAPY MARKET SIZE, BY DISEASE, 2018-2024 (USD MILLION)
TABLE 282. ASIA-PACIFIC FECAL TRANSPLANT THERAPY MARKET SIZE, BY DISEASE, 2025-2030 (USD MILLION)
TABLE 283. ASIA-PACIFIC FECAL TRANSPLANT THERAPY MARKET SIZE, BY THERAPY PROCEDURE, 2018-2024 (USD MILLION)
TABLE 284. ASIA-PACIFIC FECAL TRANSPLANT THERAPY MARKET SIZE, BY THERAPY PROCEDURE, 2025-2030 (USD MILLION)
TABLE 285. ASIA-PACIFIC FECAL TRANSPLANT THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 286. ASIA-PACIFIC FECAL TRANSPLANT THERAPY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 287. ASIA-PACIFIC FECAL TRANSPLANT THERAPY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 288. ASIA-PACIFIC FECAL TRANSPLANT THERAPY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 289. CHINA FECAL TRANSPLANT THERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 290. CHINA FECAL TRANSPLANT THERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 291. CHINA FECAL TRANSPLANT THERAPY MARKET SIZE, BY DISEASE, 2018-2024 (USD MILLION)
TABLE 292. CHINA FECAL TRANSPLANT THERAPY MARKET SIZE, BY DISEASE, 2025-2030 (USD MILLION)
TABLE 293. CHINA FECAL TRANSPLANT THERAPY MARKET SIZE, BY THERAPY PROCEDURE, 2018-2024 (USD MILLION)
TABLE 294. CHINA FECAL TRANSPLANT THERAPY MARKET SIZE, BY THERAPY PROCEDURE, 2025-2030 (USD MILLION)
TABLE 295. CHINA FECAL TRANSPLANT THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 296. CHINA FECAL TRANSPLANT THERAPY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 297. INDIA FECAL TRANSPLANT THERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 298. INDIA FECAL TRANSPLANT THERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 299. INDIA FECAL TRANSPLANT THERAPY MARKET SIZE, BY DISEASE, 2018-2024 (USD MILLION)
TABLE 300. INDIA FECAL TRANSPLANT THERAPY MARKET SIZE, BY DISEASE, 2025-2030 (USD MILLION)
TABLE 301. INDIA FECAL TRANSPLANT THERAPY MARKET SIZE, BY THERAPY PROCEDURE, 2018-2024 (USD MILLION)
TABLE 302. INDIA FECAL TRANSPLANT THERAPY MARKET SIZE, BY THERAPY PROCEDURE, 2025-2030 (USD MILLION)
TABLE 303. INDIA FECAL TRANSPLANT THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 304. INDIA FECAL TRANSPLANT THERAPY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 305. JAPAN FECAL TRANSPLANT THERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 306. JAPAN FECAL TRANSPLANT THERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 307. JAPAN FECAL TRANSPLANT THERAPY MARKET SIZE, BY DISEASE, 2018-2024 (USD MILLION)
TABLE 308. JAPAN FECAL TRANSPLANT THERAPY MARKET SIZE, BY DISEASE, 2025-2030 (USD MILLION)
TABLE 309. JAPAN FECAL TRANSPLANT THERAPY MARKET SIZE, BY THERAPY PROCEDURE, 2018-2024 (USD MILLION)
TABLE 310. JAPAN FECAL TRANSPLANT THERAPY MARKET SIZE, BY THERAPY PROCEDURE, 2025-2030 (USD MILLION)
TABLE 311. JAPAN FECAL TRANSPLANT THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 312. JAPAN FECAL TRANSPLANT THERAPY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 313. AUSTRALIA FECAL TRANSPLANT THERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 314. AUSTRALIA FECAL TRANSPLANT THERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 315. AUSTRALIA FECAL TRANSPLANT THERAPY MARKET SIZE, BY DISEASE, 2018-2024 (USD MILLION)
TABLE 316. AUSTRALIA FECAL TRANSPLANT THERAPY MARKET SIZE, BY DISEASE, 2025-2030 (USD MILLION)
TABLE 317. AUSTRALIA FECAL TRANSPLANT THERAPY MARKET SIZE, BY THERAPY PROCEDURE, 2018-2024 (USD MILLION)
TABLE 318. AUSTRALIA FECAL TRANSPLANT THERAPY MARKET SIZE, BY THERAPY PROCEDURE, 2025-2030 (USD MILLION)
TABLE 319. AUSTRALIA FECAL TRANSPLANT THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 320. AUSTRALIA FECAL TRANSPLANT THERAPY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 321. SOUTH KOREA FECAL TRANSPLANT THERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 322. SOUTH KOREA FECAL TRANSPLANT THERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 323. SOUTH KOREA FECAL TRANSPLANT THERAPY MARKET SIZE, BY DISEASE, 2018-2024 (USD MILLION)
TABLE 324. SOUTH KOREA FECAL TRANSPLANT THERAPY MARKET SIZE, BY DISEASE, 2025-2030 (USD MILLION)
TABLE 325. SOUTH KOREA FECAL TRANSPLANT THERAPY MARKET SIZE, BY THERAPY PROCEDURE, 2018-2024 (USD MILLION)
TABLE 326. SOUTH KOREA FECAL TRANSPLANT THERAPY MARKET SIZE, BY THERAPY PROCEDURE, 2025-2030 (USD MILLION)
TABLE 327. SOUTH KOREA FECAL TRANSPLANT THERAPY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 328. SOUTH KOREA FECAL TRANSPLANT THERAPY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 329. INDONESIA FECAL TRANSPLANT THERAPY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 330. INDONESIA FECAL TRANSPLANT THERAPY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 331. INDONESIA FECAL TRANSPLANT THERAPY MARKET SIZE, BY DISEASE, 2018-2024 (USD MILLION)
TABLE 332. INDONESIA FECAL TRANSPLANT THERAPY MARKET SIZE, BY DISEASE, 2025-2030 (USD MILLION)
TABLE 333. INDONESIA FECAL TRANSPLANT THERAPY MARKET SIZE, BY THERAPY PROCEDURE, 2018-2024 (USD MILLION)
TABLE 334. INDONESIA FECAL TRANSPLANT THERAPY MARKET SIZE, BY THERAPY PROCEDURE, 2025-2030 (USD MILLION)
TABLE 335. INDONESIA FECAL TRANSP

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Fecal Transplant Therapy Market report include:
  • AOBiome Therapeutics, Inc.
  • Assembly Biosciences, Inc.
  • BiomX Inc.
  • Evogene Ltd.
  • Ferring Pharmaceuticals
  • Finch Therapeutics Group, Inc.
  • MaaT Pharma
  • Nestlé Health Science
  • OpenBiome
  • Seres Therapeutics, Inc.
  • Takeda Pharmaceutical Company Limited
  • Theriva Biologics, Inc.
  • Vedanta Biosciences, Inc.
  • Taconic Biosciences, Inc.

Table Information

Report AttributeDetails
No. of Pages197
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 2.02 billion
Forecasted Market Value ( USD ) by 2030 $ 2.77 billion
Compound Annual Growth Rate6.4%
Regions CoveredGlobal
No. of Companies Mentioned15

Related Topics

Related Reports

Pharmaceuticals - Enterprise ICT - Product Image

Pharmaceuticals - Enterprise ICT

  • Report
  • 54 Pages
  • Global
From
Pharmaceuticals North America (NAFTA) Industry Guide 2019-2028 - Product Image

Pharmaceuticals North America (NAFTA) Industry Guide 2019-2028

  • Report
  • 286 Pages
  • North America
From
Asia-Pacific Pharmaceutical Industry Outlook 2023 - Product Image

Asia-Pacific Pharmaceutical Industry Outlook 2023

  • Report
  • 77 Pages
  • Asia Pacific
From
Pharmaceutical Automation - Global Strategic Business Report - Product Image

Pharmaceutical Automation - Global Strategic Business Report

  • Report
  • 371 Pages
  • Global
From
Fecal Transplant Therapy Market Report 2025 - Product Image

Fecal Transplant Therapy Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.